Company
GaDia
Developing an innovative, patented rapid in vitro diagnostic (IVD) test to detect nosocomial diseases. More specifically, the aim is to develop a new rapid Point-Of-Care (POC) predictive diagnostic test to discriminate healthcare-acquired fungal infections from other causes of infections.
Main sector
Medtech
Contact
info@gadia.net
0041796328447
Route de l’Ile-aux-Bois 1A, 1870 Monthey
Specialties
Core competencies
Antibodies & Anti-infectious, COVID-19, Diagnostic & In-Vitro Device, Medical Technology, Therapeutic & Diagnostic
Organization Type
Private Company
Key Businesses
Entreprise
Building
3
Entry
5
Floor
1 West
